Gastroenterologists take biopsies during a colonoscopy because the camera alone cannot tell them everything they need to know about your colon. A polyp that looks harmless might harbor precancerous cells, inflamed tissue that appears unremarkable might carry signs of a chronic disease, and a colon that looks perfectly normal can still have microscopic abnormalities that only show up under a pathologist’s microscope. The biopsy bridges the gap between what the doctor can see and what is actually happening at the cellular level.
Polyps Are the Most Common Reason
The single most frequent reason a gastroenterologist reaches for the biopsy forceps or snare is a polyp. Polyps are small growths on the inner lining of the colon, and during a screening colonoscopy they are found in a significant number of people, especially after age 50. When the doctor spots one, the standard practice is to remove it entirely, if possible, and send the tissue to a pathology lab. Removing polyps is both diagnostic and preventive at the same time: the lab determines what type of polyp it was, and removing it eliminates the chance it could grow into something worse.
Not all polyps carry the same risk. A large study examining over 550,000 polyps found that growths of every size could contain a range of tissue types, from completely harmless hyperplastic polyps to tubular adenomas, tubulovillous adenomas, sessile serrated polyps, and even outright adenocarcinoma.1American Journal of Gastroenterology. Lesions of All Types Exist in Colon Polyps of All Sizes The doctor cannot reliably distinguish between these types just by looking at a polyp through the camera. Size and shape give clues, but the only definitive way to classify a polyp is to examine the tissue under a microscope.
This matters because certain polyp types are precursors to colorectal cancer while others are not. Sessile serrated polyps, for example, are now recognized as likely precursor lesions for many colorectal cancers, and they were historically underdiagnosed because pathologists sometimes lumped them together with ordinary hyperplastic polyps.2PubMed. Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: implications for polyp surveillance recommendations Without sending the tissue for analysis, there would be no way to catch these higher-risk growths.
Biopsies From Normal-Looking Tissue
This is the part that surprises many patients. Sometimes the gastroenterologist takes biopsies even when the colon looks completely healthy through the camera. There are good reasons for this, and the practice has solid evidence behind it. Research has shown that significant pathology can be missed if doctors skip biopsies of apparently normal-looking colon tissue.3PubMed. Is biopsy necessary if colonoscopy is normal?
The most clear-cut example is microscopic colitis. This condition causes chronic watery diarrhea but produces no visible changes to the colon lining during a colonoscopy. The mucosa looks entirely normal. The diagnosis can only be made by examining biopsy tissue under a microscope, where a pathologist can spot the telltale thickened collagen band or the infiltration of certain white blood cells that define the two main subtypes of the disease.4European Journal of Gastroenterology & Hepatology. Estimating the optimum number of colon biopsies for diagnosing microscopic colitis: a systematic review Research has found that biopsies taken from just the ascending and descending colon can catch microscopic colitis in over 90% of cases.5Clinical Gastroenterology and Hepatology. Biopsies From Ascending and Descending Colon Are Sufficient for Diagnosis of Microscopic Colitis
If you have been referred for a colonoscopy because of persistent diarrhea, expect random biopsies from several locations even if nothing abnormal is visible. The doctor is specifically looking for conditions that hide from the camera.
Diagnosing Inflammatory Bowel Disease
For patients with symptoms that suggest Crohn’s disease or ulcerative colitis, biopsies play a central role in nailing down the diagnosis and distinguishing between the two. Both conditions cause inflammation in the gut, but they do so in different patterns that a pathologist can identify from the tissue samples. Studies have found that biopsy-based criteria can differentiate Crohn’s disease from ulcerative colitis with sensitivity above 90% and specificity above 93%.6PubMed. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity
Getting the right diagnosis matters enormously because the two diseases call for different treatment strategies and carry different long-term risks. Crohn’s disease can affect any part of the digestive tract and tends to create patchy, deep inflammation. Ulcerative colitis is confined to the colon and rectum and causes continuous surface-level inflammation. Blood tests and imaging help, but the biopsy findings often tip the balance when the clinical picture is ambiguous.
For people who already have a confirmed inflammatory bowel disease diagnosis, biopsies continue to be important at follow-up colonoscopies. Long-standing inflammation in the colon raises the risk of developing dysplasia, which is the earliest cellular change on the path toward colorectal cancer. Surveillance programs for ulcerative colitis and Crohn’s colitis rely on taking multiple biopsies throughout the colon to catch dysplasia early, when it can still be managed, ideally before cancer develops.7PubMed Central. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn’s disease of the colon
Infections and Unexpected Diagnoses
Biopsies sometimes reveal conditions that nobody expected going in. Infections are a good example. Cytomegalovirus (CMV) can cause colitis that mimics other conditions, and the diagnosis often hinges on finding characteristic viral inclusions in biopsy tissue. In one reported case, a patient whose colonoscopy findings looked like ischemic colitis turned out to have CMV colitis, diagnosed only after the biopsy showed the classic viral changes in the tissue. The correct diagnosis allowed targeted antiviral treatment and a full recovery.8PubMed Central. A Case of Amyloid Light-Chain Amyloidosis Presenting as Colitis
Systemic diseases occasionally announce themselves through the colon as well. Amyloidosis, a condition in which abnormal proteins build up in organs, has been diagnosed from colon biopsies when patients presented with what appeared to be ordinary colitis. A colonoscopy might show ulceration and swelling suggestive of ischemic colitis, but the biopsy reveals amyloid deposits confirmed by special staining techniques. Without the tissue sample, these rare but important diagnoses would be missed entirely.
How the Biopsy Actually Happens
If you are wondering whether taking a biopsy adds pain or significant time to the procedure, the short answer is that most people do not feel it at all. The inner lining of the colon does not have the same pain-sensing nerve fibers as your skin. The most common technique for small biopsies uses tiny forceps passed through a channel in the colonoscope. The doctor opens the forceps, presses them against the tissue, and pinches off a piece roughly the size of a grain of rice.
For polyp removal, the technique depends on the polyp’s size. Small polyps are often removed with a cold snare, which is a thin wire loop that lassoes the polyp and slices it off without using electrical current. A randomized trial comparing cold snare polypectomy to cold forceps polypectomy for small polyps found that both methods are effective, though they differ in how completely they remove all polyp tissue.9PubMed. Cold snare polypectomy versus cold forceps polypectomy for diminutive and small colorectal polyps: a randomized controlled trial Larger polyps may require a hot snare, which uses electrical current to cut and cauterize simultaneously, or more advanced techniques for flat or difficult growths.
All removed tissue goes into labeled containers, one per biopsy site, and is sent to a pathology laboratory for processing. The samples are preserved, embedded in wax, sliced into extremely thin sections, stained, and examined under a microscope by a pathologist. Special stains or molecular tests can be added when the clinical question calls for them.
What the Risks Look Like
Taking biopsies does add a small amount of risk compared to a colonoscopy where the doctor only looks. A large study in an integrated health system found that serious complications occurred in about 1 in 1,250 colonoscopies without biopsy, compared to about 7 in 1,000 colonoscopies that included a biopsy or polypectomy.10PubMed. Complications of colonoscopy in an integrated health care delivery system The two main risks are bleeding and perforation. Post-biopsy bleeding occurred in roughly 5 out of every 1,000 procedures that included a biopsy, and perforations were rarer still.10PubMed. Complications of colonoscopy in an integrated health care delivery system
Perforation, a hole through the colon wall, is the complication doctors worry about most because it often requires surgery. It occurs through three main mechanisms: direct mechanical puncture from the scope or biopsy instrument, excessive air pressure during the procedure, and complications during therapeutic maneuvers like large polyp removal or stricture dilation. The risk is under 1% for diagnostic colonoscopies and can rise to around 3% for more complex therapeutic procedures.11PubMed. Colonoscopic perforations. Etiology, diagnosis, and management
To put these numbers in perspective, the overwhelming majority of biopsies cause no complications at all. A tiny forceps biopsy from a flat surface carries less risk than snaring off a large polyp. The benefit of catching precancerous tissue or diagnosing a treatable condition almost always outweighs the small procedural risk, which is why guidelines recommend removing polyps and sampling suspicious tissue rather than adopting a “watch and wait” approach.
Waiting for Results and What They Mean
The wait between your colonoscopy and receiving biopsy results is often the most stressful part. Your gastroenterologist usually gives you preliminary findings right after the procedure: how many polyps were found, their approximate size, whether anything looked concerning. But the definitive answers come from the pathology report, which typically takes days to a couple of weeks. The timeline involves several steps: the tissue has to be processed and embedded, slides have to be prepared and stained, and a pathologist has to examine them and write a report. The report then goes back to your doctor, who reviews it and communicates the results to you.
Qualitative research into patient experiences has highlighted how this waiting period generates anxiety, especially when the timeline stretches longer than expected. In one study, a patient described being told results would come in two to three weeks, then waiting nearly six weeks with growing worry.12Journal of the Canadian Association of Gastroenterology. Patient Experiences with Colonoscopy: A Qualitative Study If you have not heard back by the timeframe your doctor mentioned, call the office. Delays are common for administrative reasons and rarely mean the news is bad.
Efforts are underway to speed up pathology turnaround. Some centers have started using deep learning models trained on tens of thousands of digitized biopsy images to help prioritize cases, flagging potentially cancerous samples for faster review.13PubMed. A deep learning approach to case prioritisation of colorectal biopsies These tools do not replace the pathologist, but they can help ensure that the most urgent cases are not sitting in a queue behind routine ones.
How Biopsy Results Shape Your Next Colonoscopy
One of the most practical consequences of biopsy findings is that they directly determine when you need your next colonoscopy. Guidelines published by major gastroenterology societies lay out a detailed surveillance schedule based on what the pathologist finds in your tissue samples. If your colonoscopy was completely clean, the recommendation is typically to wait ten years before doing it again. But if polyps were found, the type, number, and size all matter.
A few small tubular adenomas under 10 mm can push your next colonoscopy to seven to ten years out. Finding three or four of them shortens the interval to three to five years. Polyps with certain features, such as villous architecture, high-grade dysplasia, or a size of 10 mm or larger, call for a repeat in three years. And if more than ten adenomas turn up, guidelines recommend coming back in just one year.14Gastroenterology. Follow-up after colonoscopy and polypectomy Sessile serrated lesions follow a similar pattern, with larger or more numerous ones warranting closer follow-up, and serrated polyposis syndrome calling for annual surveillance.15PubMed Central. Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program
Small hyperplastic polyps in the lower part of the colon, by contrast, are considered low-risk, and finding them generally does not shorten the surveillance interval at all. This is where the biopsy pays off most clearly: what looked like just “a polyp” during the procedure could range from something completely harmless to something that places you on a more intensive monitoring track. Without the pathology results, your doctor would have no rational basis for choosing the right follow-up schedule.
Molecular Testing From Biopsy Tissue
Biopsy samples are increasingly used for more than just looking at cells through a microscope. Molecular and genetic tests performed on biopsy tissue can identify inherited cancer syndromes and guide treatment decisions. One important example is Lynch syndrome, a hereditary condition that dramatically increases the risk of colorectal and other cancers. Tumor tissue from a biopsy can be tested for microsatellite instability, a molecular signature that suggests the DNA repair machinery in those cells is not working properly.
Research has shown that a multiplex assay can reliably detect high microsatellite instability in colonoscopic biopsies from Lynch syndrome patients, with results comparable to those obtained from surgically removed tumor specimens.16PubMed Central. Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR Assay This means that a small biopsy taken during a routine colonoscopy can trigger a cascade of genetic testing and family screening that catches an inherited cancer risk early, potentially saving lives beyond just the patient in the exam room.
Despite the potential, screening for Lynch syndrome is not yet universal. A population-based study of colorectal cancer patients aged 50 and under found that microsatellite instability or related testing was performed in only about 23% of cases, even though this younger age group is exactly where inherited syndromes are most likely to be found.17American Journal of Gastroenterology. Population-Based Lynch Syndrome Screening by Microsatellite Instability in Patients ≤50 Awareness is growing and guidelines are broadening, but there is still a gap between what biopsy tissue can reveal and how consistently those tests are ordered.
The Future of “Optical Biopsy”
Researchers are working on technologies that could one day provide biopsy-level information without removing any tissue at all. The concept is called optical biopsy: using advanced imaging, specialized light wavelengths, or artificial intelligence to analyze tissue in real time while the doctor is still looking through the colonoscope. One approach uses hyperspectral imaging combined with neural networks to distinguish cancerous from healthy tissue during the procedure itself.18PubMed. Automatic optical biopsy for colorectal cancer using hyperspectral imaging and artificial neural networks
These technologies are still largely in the research phase. The promise is appealing: immediate answers, no waiting for pathology, no tissue removal for polyps that turn out to be harmless. Some gastroenterologists already use enhanced imaging modes built into modern colonoscopes, like narrow-band imaging, to make preliminary judgments about whether a tiny polyp is likely to be benign. But for now, physical biopsy remains the gold standard. Optical methods are not yet accurate or validated enough to replace the pathologist’s microscope for anything beyond the smallest, most clearly benign-looking growths. When the stakes include cancer detection, the field is understandably cautious about moving away from tissue-based diagnosis.
What optical biopsy could realistically change in the near term is the handling of diminutive polyps, those under 5 mm. If an AI-assisted system could confidently identify these tiny growths as hyperplastic during the procedure, the doctor might choose to remove and discard them without sending them to the lab, saving time and cost while still removing the polyp. For anything larger or more ambiguous, expect traditional biopsies to remain the standard for a long time.